← Eichor
Study identifier: NCT06473610 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Residual Embolism Evaluated With Single Photon Emission Computed Tomography

Condition: Pulmonary Circulation Obstruction  ·  Sponsor: Centre Hospitalier Universitaire de Saint Etienne

PhaseN/A
Planned participants358
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Major progress achieved in diagnostic and therapeutic strategies has substantially improved the short-term prognosis of patients with pulmonary embolism (PE). These improvements have led to a shift from an acute to a chronic condition of venous thromboembolism, justifying the recent development of Chronic Thrombo-embolic Disease (CTED). In most of the situations, it is due to a residual pulmonary vascular obstruction (RPVO) which can be assessed by pulmonary scintigraphy.

This description comes directly from the study's public registry record.

Talk to the study team

Pierre-Benoit BONNEFOY, MD  ·  (0)4 77 82 94 43  ·  pierre-benoit.bonnefoy@chu-st-etienne.fr

NATHALIE PREVOT, MD  ·  (0)4 77 82 94 43  ·  nathalie.prevot@chu-st-etienne.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Centre Hospitalier UniversitaireSaint-Etienne, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06473610